Keybank National Association OH Boosts Holdings in Waters Corporation $WAT

Keybank National Association OH boosted its holdings in shares of Waters Corporation (NYSE:WAT) by 113.0% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 3,876 shares of the medical instruments supplier’s stock after buying an additional 2,056 shares during the quarter. Keybank National Association OH’s holdings in Waters were worth $1,154,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Zions Bancorporation National Association UT boosted its stake in shares of Waters by 121.2% during the 4th quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 40 shares during the last quarter. SHP Wealth Management bought a new position in Waters in the 4th quarter worth $32,000. DV Equities LLC purchased a new position in Waters during the fourth quarter valued at $32,000. Louisbourg Investments Inc. purchased a new position in Waters during the first quarter valued at $30,000. Finally, North Star Investment Management Corp. grew its holdings in Waters by 10,200.0% during the first quarter. North Star Investment Management Corp. now owns 103 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 102 shares during the period. 94.01% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on WAT shares. Piper Sandler started coverage on Waters in a research note on Thursday, June 11th. They issued a “neutral” rating and a $400.00 price objective on the stock. Wolfe Research initiated coverage on shares of Waters in a report on Tuesday, June 2nd. They issued an “outperform” rating and a $425.00 target price for the company. TD Cowen raised their target price on shares of Waters from $345.00 to $385.00 and gave the stock a “hold” rating in a research note on Wednesday, May 6th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $350.00 price target on shares of Waters in a report on Thursday, May 7th. Finally, Evercore reissued an “outperform” rating and issued a $410.00 price objective on shares of Waters in a research note on Monday. Four investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $399.84.

Waters Stock Performance

NYSE:WAT opened at $374.94 on Wednesday. The company has a current ratio of 1.79, a quick ratio of 1.13 and a debt-to-equity ratio of 0.32. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $414.15. The stock has a 50-day moving average price of $354.18 and a 200 day moving average price of $346.74. The stock has a market capitalization of $36.82 billion, a P/E ratio of 47.64, a P/E/G ratio of 2.29 and a beta of 1.20.

Waters (NYSE:WAT) last posted its quarterly earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 EPS for the quarter, topping analysts’ consensus estimates of $2.31 by $0.39. Waters had a return on equity of 15.60% and a net margin of 11.91%.The company had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.20 billion. During the same period in the previous year, the firm earned $2.25 EPS. The firm’s revenue was up 91.4% compared to the same quarter last year. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Equities research analysts forecast that Waters Corporation will post 14.51 EPS for the current fiscal year.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.